Track topics on Twitter Track topics that are important to you
MONDAY, March 20, 2017 -- A blood test can detect the return of lung cancer months before CT and PET scans, a new study suggests. The research included 48 adults with stage 2 or 3 locally advanced non-small cell lung cancer (NSCLC). The patients...
Original Article: Blood Test May Spot Lung Cancer's Return, Even Before ScansNEXT ARTICLE
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...
GILOTRIF (afatinib) is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L8...